GlucoTrack Stock Forecast - Downside Variance

GCTK Stock  USD 0.36  1.21  77.07%   
GlucoTrack Stock Forecast is based on your current time horizon. Although GlucoTrack's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of GlucoTrack's systematic risk associated with finding meaningful patterns of GlucoTrack fundamentals over time.
  
At this time, GlucoTrack's Inventory Turnover is quite stable compared to the past year. Receivables Turnover is expected to rise to 4.90 this year, although the value of Payables Turnover will most likely fall to 0.01. . Common Stock Shares Outstanding is expected to rise to about 4.9 M this year, although the value of Net Loss will most likely fall to (5.4 M).
GlucoTrack has current Downside Variance of 0.
Check GlucoTrack VolatilityBacktest GlucoTrackInformation Ratio  

GlucoTrack Trading Date Momentum

On November 13 2024 GlucoTrack was traded for  0.36  at the closing time. The top price for the day was 0.46  and the lowest listed price was  0.34 . The trading volume for the day was 6.5 M. The trading history from November 13, 2024 did not cause price change. The overall trading delta against the current closing price is 22.22% .
Compare GlucoTrack to competition

Other Forecasting Options for GlucoTrack

For every potential investor in GlucoTrack, whether a beginner or expert, GlucoTrack's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GlucoTrack Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GlucoTrack. Basic forecasting techniques help filter out the noise by identifying GlucoTrack's price trends.

GlucoTrack Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GlucoTrack stock to make a market-neutral strategy. Peer analysis of GlucoTrack could also be used in its relative valuation, which is a method of valuing GlucoTrack by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

GlucoTrack Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of GlucoTrack's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of GlucoTrack's current price.

GlucoTrack Market Strength Events

Market strength indicators help investors to evaluate how GlucoTrack stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlucoTrack shares will generate the highest return on investment. By undertsting and applying GlucoTrack stock market strength indicators, traders can identify GlucoTrack entry and exit signals to maximize returns.

GlucoTrack Risk Indicators

The analysis of GlucoTrack's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in GlucoTrack's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting glucotrack stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether GlucoTrack is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlucoTrack Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glucotrack Stock. Highlighted below are key reports to facilitate an investment decision about Glucotrack Stock:
Check out Historical Fundamental Analysis of GlucoTrack to cross-verify your projections.
For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.66)
Return On Assets
(1.57)
Return On Equity
(5.41)
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.